Q2 2017 13F Holders as of 30 Jun 2017
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,361,296
-
Number of holders
-
48
-
Total 13F shares, excl. options
-
17,504,516
-
Shares change
-
+169,419
-
Total reported value, excl. options
-
$211,804,598
-
Value change
-
-$2,803,453
-
Number of buys
-
34
-
Number of sells
-
-22
-
Price
-
$12.10
Significant Holders of Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) as of Q2 2017
64 filings reported holding CRVS - Corvus Pharmaceuticals, Inc. - Common Stock as of Q2 2017.
Corvus Pharmaceuticals, Inc. - Common Stock (CRVS) has 48 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 17,504,516 shares
of 74,361,296 outstanding shares and own 23.5% of the company stock.
Largest 10 shareholders include ORBIMED ADVISORS LLC (5,379,349 shares), Novo Holdings A/S (3,244,046 shares), ADAMS STREET PARTNERS LLC (2,687,381 shares), FMR LLC (1,050,611 shares), JENNISON ASSOCIATES LLC (1,019,013 shares), EcoR1 Capital, LLC (805,000 shares), Rock Springs Capital Management LP (422,600 shares), VANGUARD GROUP INC (373,512 shares), BlackRock Inc. (369,202 shares), and PRICE T ROWE ASSOCIATES INC /MD/ (344,601 shares).
This table shows the top 48 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.